Neurol. praxi. 2013;14(4):210-211

Léčba první volby u CIDP. Kortikoidy nebo IVIg?

prof. MUDr. Zdeněk Ambler, DrSc.1, prof. MUDr. Josef Bednařík, CSc.2
1 Neurologická klinika LF UK a FN v Plzni
2 Neurologická klinika FN a LF MU Brno

Published: October 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ambler Z, Bednařík J. Léčba první volby u CIDP. Kortikoidy nebo IVIg? Neurol. praxi. 2013;14(4):210-211.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Blackhouse G, Gaebel K, Xie F, Campbell K, Assasi N, Tarride J-E, O'Reilly D, Chalk C, Levine M, Goeree R. Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in Canada. Cost Eff Resour Alloc 2010; 8: 14. Go to original source... Go to PubMed...
    2. Brannagan TH III. Current treatments of chronic immune-mediated demyelinating polyneuropathies. Muscle Nerve 2009; 39: 563-578. Go to original source... Go to PubMed...
    3. Cocito D, Paolasso I, Antonini G, Benedetti L, Briani C, Comi C, Fazio R, Jann S, Mat? S, Mazzeo A, Sabatelli M, Nobile-Orazio E. Italian network for CIDP register. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2010; 17: 289-294. Go to original source... Go to PubMed...
    4. Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, Nobile-Orazio E, van Doorn P, Dalakas M, Bojar M, Swan A. Inflammatory neuropathy cause and treatment (INCAT) group. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001; 50: 195-201. Go to original source... Go to PubMed...
    5. Lopate G, Pestronk A, Al-Lozi M. Treatment of chronic inflammatory demyelinating neuropathy with high-dose intermittent intravenous methylprednisolone. Arch Neurol 2005; 62: 249-254. Go to original source... Go to PubMed...
    6. Muley SA, Kelkar P, Parry GJ. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids. Arch Neurol. 2008; 65: 1460-1464. Go to original source... Go to PubMed...
    7. Robertson EE, Donofrio PD. Treatment of chronic inflammatory demyelinating polyneuropathy. Curr Treat Option N 2010; 12: 84-94. Go to original source... Go to PubMed...
    8. Sladky JH. What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin? Muscle Nerve 2008; 38: 1638-1643. Go to original source... Go to PubMed...
    9. Van den Bergh PYK, Hadden RDM, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Léger J-M, Nobile-Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision. Europ J Neurol 2010; 17: 356-363. Go to original source... Go to PubMed...
    10. Yoon M-S, Chan A. Gold R. Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Ther Adv Neurol Disord 2011; 4: 193-200. Go to original source... Go to PubMed...
    11. ##
    12. Austin JH. Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone and prednisone. Brain 1958; 81: 157-192. Go to original source... Go to PubMed...
    13. Dyck PJ, O'Brien PC, Oviatt KF. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982; 11: 136-141. Go to original source... Go to PubMed...
    14. Van Schaik IN, Winer JB, de Haan R, Vermeulen M. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2002; 2: CD001797. Go to original source... Go to PubMed...
    15. Hughes RA, Donofrio P, Bril V, et al. Intravenous immune globulin (10% caprylatechromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 2008; 7: 136-144. Go to original source... Go to PubMed...
    16. Merkies IS, Bril V, Dalakas MC, et al. Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study. Neurology 2009; 72: 1337-1344. Go to original source... Go to PubMed...
    17. Hughes RAC, Bouche P, Cornblath DR, Evers E, Hadden RDM, Hahn A, Illa I, Koski CL, Léger JM, Nobile-Orazio E, Pollard J, Sommer C, Van den Bergh P, van Doorn PA, van Schaik IN. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006; 13: 326-332. Go to original source... Go to PubMed...
    18. Elovaara I, Apostolski S, van Doorn P, Gilhus NE, Hietaharju A, Honkaniemi J, van Schaik IN, Scolding N, Soelberg S?rensen P, Udd B. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases. EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol 2008, 15: 893-908. Go to original source... Go to PubMed...
    19. Bednařík J, Voháňka S, Ehler E, Amber Z, Piťha J, Veckovský J, Litzman J, Kořistek Z, Suchý M, Pátá M, Kožený P. Standard pro léčbu pacientů s autoimunitními nervosvalovými onemocněními intravenózním lidským imunoglobulinem a plazmaferézou. Cesk Slov Neurol N 2010; 73/106: 579-589.
    20. Van Schaik IN, Eftimov F, van Doorn PA, Brusse E, van den Berg LH, van der Pol WL et al. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol 2010; 9: 245-253. Go to original source... Go to PubMed...
    21. Blackhouse G, Gaebel K, Xie F, et al. Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Cost Effectiveness and Resource Allocation 2010, 8: 14. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.